期刊文献+

延边地区341例慢性丙型肝炎病毒基因分型的检测临床观察 被引量:1

Clinical observation of 341 cases of chronic hepatitis C virus genotyping in Yanbian area
下载PDF
导出
摘要 [背景]观察延边地区慢性丙型肝炎病毒(HCV)基因分型情况.[病例报告]采用荧光PCR法检测HCV RNA含量,并对含量≥104 U/mL的341例标本进行HCV基因分型检测.结果见,慢性HCV基因Ⅰ型阳性的朝鲜族和汉族分别为48,68例,阳性率分别为37.2%,32.1%,两者间差异无统计学意义(χ~2=0.942,P〉0.05);慢性HCV基因Ⅰ型阳性的男性和女性分别为97,19例,阳性率分别为36.7%,24.7%,两者间差异有统计学意义(χ~2=3.867,P〈0.05).[讨论]延边地区朝鲜族和汉族慢性HCV基因Ⅰ型感染阳性率间无明显差异,但性别间有显著差异. BACKGROUNDTo observe the chronic hepatitis C virus(HCV)genotyping in Yanbian area.CASE REPORTS HCV RNA quantification was analyzed by FQ-PCR,and the genotypes were detected from 341 specimens with more than ≥104 U/mL.The positive number of chromic HCV genotype I in Korean-Chinese and Han nationality was 48,68,and its positive rate was 37.2%,32.1%,respectively,and there was no significant difference between Korean-Chinese and Han nationality(χ2=0.942,P〈0.05).The positive number of chromic HCV genotype I in male and female patients was 97,19,and its positive rates was 36.7%,24.7%,respectively,and there was a significantly different between male and female patients(χ2=3.867,P〈0.05).DISCUSSIONThe infection positive rate of chromic HCV genotype I is no significant difference between Korean-Chinese and Han nationality in Yanbian area,but is significant difference between male and female.
出处 《延边大学医学学报》 CAS 2015年第4期313-314,共2页 Journal of Medical Science Yanbian University
关键词 丙型肝炎病毒 基因型 民族 性别 hepatitis C virus gonotype nation gender
  • 相关文献

参考文献10

  • 1丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 2Núnez M,Ríos P,Martin-carbonero L,et al..Role of hepatitis C virus genotype in the development of severe transaminase elevation after the introduction of antiretroviral therapy[J].J Acquir Immune Defic Syndr,2002,30(1):65-68.
  • 3赵桂珍,安萍,黄芬,李颖.丙型肝炎病毒基因型及其病毒RNA定量与干扰素疗效的关系[J].中国医科大学学报,2000,29(6):445-447. 被引量:6
  • 4庄辉.重视丙型肝炎的研究[J].中华肝脏病杂志,2004,12(2):65-66. 被引量:44
  • 5Mellor J,Holmes EC,Jarvis LM,et al..Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions:implications for virus classification[J].J Gen Virol,1995,76(3):2493-2507.
  • 6Simmonds P,Bukh L,Combet C,et al..Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes[J].Hepatology,2005,42(4):962-973.
  • 7Chemello L,Bonetti P,Cavalletto L,et al..Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C the triveneto viral hepatitis group[J].Hepatology,1995,22(3):700-706.
  • 8Martinot-Peignoux M,Marcellin P,Pouteau M,et al..Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotypes are the main and independent prognostic factors of sustained reponse to interferon alfa therapy in chronic hepatitis C[J].Hepatology,1995,22(4):1050-1056.
  • 9Féray C,Gigou M,Samuel D,et al..Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation[J].Gastroenterology,1995,108(4):1088-1096.
  • 10庄辉,Tracy L,崔怡辉,凌斌华,张玲霞,Bowden S.我国部分地区丙型肝炎病毒基因分型研究[J].中华流行病学杂志,2001,22(2):99-101. 被引量:29

二级参考文献25

  • 1杜绍财,陶其敏.丙型肝炎病毒基因5‘—末端非编码区酶切分型研究[J].中华医学杂志,1993,73(1):7-9. 被引量:45
  • 2病毒性肝炎防治方案(试行)[J].中华传染病杂志,1995,13(4):241-247. 被引量:1767
  • 3唐小平,袁小珍,吴婉芬,许永俊.丙型肝炎病毒基因酶切分型及其在干扰素治疗中的应用[J].中华实验和临床病毒学杂志,1996,10(3):258-261. 被引量:3
  • 4葛宪民,王树声,李丹亚,沟上雅史,吴蓉蓉,黄果勇,李茵,王缨,曹堃,潘海东,王红,周开姣,章玲珠,钱小燕,哲户悦朗,大野智仪,铃木馨,大羽健一.广西吸毒者、肝病患者及献血员丙型肝炎病毒血清学基因型和基因型的分子生物学研究[J].中华实验和临床病毒学杂志,1996,10(4):312-317. 被引量:6
  • 5Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
  • 6Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
  • 7Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
  • 8Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
  • 9Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137.
  • 10Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12.

共引文献806

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部